Trial Profile
Use of Eslicarbazepine in children and adolescents with refractory epilepsy in relation to age,comedication and duration of treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2017
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 13 Nov 2017 New trial record